Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Alvotech (NASDAQ: ALVO) tekur þátt í árlegri heilbrigðisráðstefnu fjárfestingabankans Morgans Stanleys sem haldin verður í tuttugasta og fyrsta sinn í New York dagana 11.-13. september nk. Ming...
-
Alvotech (NASDAQ: ALVO, „félagið“) tilkynnti í dag um breytingar í framkvæmdastjórn félagsins. Faysal Kalmoua hefur verið skipaður framkvæmdastjóri rekstrar og Hafrún Friðriksdóttir lætur af störfum....
-
Alvotech (NASDAQ: ALVO, the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that Faysal Kalmoua has...
-
REYKJAVIK, Iceland, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO, the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for...
-
Product revenue for the first six months of 2023 increased to $22.7 million, compared to $3.9 million for the same period in 2022Investors, including Teva Pharmaceuticals, subscribed to Alvotech’s...
-
Product revenue for the first six months of 2023 increased to $22.7 million, compared to $3.9 million for the same period in 2022Investors, including Teva Pharmaceuticals, subscribed to Alvotech’s...
-
Alvotech birtir uppgjör fyrir fyrri helming ársins 2023 og kynnir helstu áfanga á liðnum ársfjórðung
Sölutekjur fyrstu sex mánuði ársins jukust í 22,7 milljónir dollara samanborið við 3,9 milljónir dollara á sama tímabili í fyrraFjárfestar á Íslandi, auk Teva Pharmaceuticals Inc., skuldbundu sig til...
-
Þetta er í annað sinn sem samstarfsfélögin tryggja markaðsleyfi fyrir líftæknilyfjahliðstæðu Alvotech í Miðausturlöndum Alvotech (NASDAQ: ALVO) og Bioventure, dótturfyrirtæki GlobalOne Healthcare...
-
Approval of Adalimumab-EVA™ represents the second biosimilar approval under the strategic partnership between Alvotech and Bioventure Alvotech (NASDAQ: ALVO) and Bioventure, a wholly owned...
-
REYKJAVIK, Iceland and DUBAI, United Arab Emirates, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO) and Bioventure, a wholly owned subsidiary of GlobalOne Healthcare Holding LLC, today...